Get started
Author

Rikhia Chakraborty

Observed names: Chakraborty, Rikhia, R. Chakraborty
Observed institutions: Cleveland State University, Houston Methodist, Cleveland Clinic, Baylor College of Medicine, Texas Children's Hospital, Dan L Duncan Comprehensive Cancer Center
ORCID: 0000-0002-6661-8079
Observed ORCID: 0000-0002-6661-8079
OpenAlex ID: A5006453605
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
2014 · Marie-Luise Berres, Karen Phaik Har Lim, et al. · The Journal of Experimental Medicine · 442
PDF
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis
2014 · Rikhia Chakraborty, Oliver A. Hampton, et al. · Blood · 431
PDF
Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis
2016 · Rikhia Chakraborty, Thomas M. Burke, et al. · Blood · 172
PDF
CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH‐associated neurodegeneration and mass lesions
2018 · Kenneth L. McClain, Jennifer Picarsic, et al. · Cancer · 137
PDF
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
2024 · Meenakshi Hegde, Shoba Navai, et al. · Nature Cancer · 110
PDF
Differentiating Skin-Limited and Multisystem Langerhans Cell Histiocytosis
2014 · Stephen J. Simko, Benjamin Garmezy, et al. · The Journal of Pediatrics · 102
Redox Regulation of Interleukin-4 Signaling
2008 · Pankaj Sharma, Rikhia Chakraborty, et al. · Immunity · 99
PDF
RAF/MEK/extracellular signal–related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions
2017 · Brandon Hogstad, Marie-Luise Berres, et al. · The Journal of Experimental Medicine · 85
PDF
BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology
2021 · Camille Bigenwald, Jessica Le Berichel, et al. · Nature Medicine · 83
Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications.
2016 · Daniel J Zinn, Rikhia Chakraborty, et al. · PubMed · 70
Activation of Wnt Signaling Arrests Effector Differentiation in Human Peripheral and Cord Blood-Derived T Lymphocytes
2011 · Sujatha Muralidharan, Patrick J Hanley, et al. · The Journal of Immunology · 69
PDF
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS
2021 · Howard Lin, Brooks P. Scull, et al. · Blood Advances · 65
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
2015 · Marie-Luise Berres, Karen Phaik Har Lim, et al. · The Journal of Experimental Medicine · 54
PDF
New somatic BRAF splicing mutation in Langerhans cell histiocytosis
2017 · Sébastien Héritier, Zofia Hélias-Rodzewicz, et al. · Molecular Cancer · 53
PDF
Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH
2020 · Amel Sengal, Jessica Velazquez, et al. · Blood · 48
Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells
2020 · Karen Phaik Har Lim, Paul Milne, et al. · Blood Advances · 43
Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease
2012 · R. Chakraborty, A. Mahendravada, et al. · Haematologica · 38
PDF
Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma
2017 · Rikhia Chakraborty, Oliver A. Hampton, et al. · Oncotarget · 37
MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age
2020 · Rikhia Chakraborty, Omar Abdel-Wahab, et al. · Cold Spring Harbor Perspectives in Medicine · 31
PDF
A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility
2017 · Erin C. Peckham-Gregory, Rikhia Chakraborty, et al. · Blood · 25
PDF
p53 Nongenotoxic Activation and mTORC1 Inhibition Lead to Effective Combination for Neuroblastoma Therapy
2017 · Myrthala Moreno-Smith, Anna Lakoma, et al. · Clinical Cancer Research · 25
BRAFV 600E or mutant MAP2K1 human CD34+ cells establish Langerhans cell–like histiocytosis in immune-deficient mice
2020 · Anahita Rafiei, C. Matthias Wilk, et al. · Blood Advances · 19
PDF
Mutually Exclusive Recurrent Somatic Mutations in MAP2K1 and BRAF Support a Central Role for ERK Activation in LCH Pathogenesis
2014 · Rikhia Chakraborty · Blood · 16
Cellular distribution of mutations and association with disease risk in Langerhans cell histiocytosis without BRAFV600E
2022 · Paul Milne, Harshal Abhyankar, et al. · Blood Advances · 15
PDF
Evaluation of maternal and perinatal characteristics on childhood lymphoma risk: A population‐based case‐control study
2016 · Erin C. Peckham‐Gregory, Heather E. Danysh, et al. · Pediatric Blood & Cancer · 13
Works count: 89
Citation count: 2,318
H-index: 21
I10-index: 26
Year
Topic
Type